Concepedia

Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

Dan Siskind, Andrea Baker, Urška Arnautovska, Nicola Warren, Anthony Russell, Veronica Eileen DeMonte, Sean Halstead, Ravi Iyer, Nicole Korman, Gemma McKeon,

The Lancet Psychiatry · 2025 · 36 citations · 22 references

DOI

Concepts

References

22

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler · Schizophrenia Bulletin · 1987 · 21.4K citations · Full text

, , +17

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II

John B. Saunders, Olaf Gjerløw Aasland, Thomas F. Babor et al. · Addiction · 1993 · 13.3K citations

, , +12

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text

, , +11

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun et al. · New England Journal of Medicine · 2023 · 2.6K citations · Full text

, , +17

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls

Christoph U. Correll, Marco Solmi, Nicola Veronese et al. · World Psychiatry · 2017 · 1.7K citations · Full text

, , +17